Maridea Wealth Management LLC Sells 2,398 Shares of Lam Research Corporation $LRCX

Maridea Wealth Management LLC reduced its position in Lam Research Corporation (NASDAQ:LRCX) by 36.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned 4,259 shares of the semiconductor company’s stock after selling 2,398 shares during the period. Maridea Wealth Management LLC’s holdings in Lam Research were worth $729,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in LRCX. Stance Capital LLC bought a new position in Lam Research during the 3rd quarter worth about $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research in the 2nd quarter valued at about $27,000. Triumph Capital Management purchased a new stake in shares of Lam Research in the 3rd quarter worth approximately $27,000. Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research in the 2nd quarter worth approximately $29,000. Finally, Delos Wealth Advisors LLC bought a new position in shares of Lam Research during the second quarter valued at approximately $30,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Lam Research

In related news, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the transaction, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. This trade represents a 4.42% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Ava Harter sold 1,500 shares of Lam Research stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total transaction of $333,990.00. Following the completion of the sale, the insider owned 53,205 shares of the company’s stock, valued at $11,846,625.30. This trade represents a 2.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 130,886 shares of company stock worth $29,658,802. Insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

Shares of LRCX stock opened at $228.36 on Monday. The business’s fifty day simple moving average is $226.92 and its 200-day simple moving average is $178.13. The company has a market cap of $285.17 billion, a PE ratio of 46.80, a PEG ratio of 2.46 and a beta of 1.77. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $256.68.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter last year, the firm earned $0.91 EPS. The business’s quarterly revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a $0.26 dividend. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio (DPR) is currently 21.31%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on LRCX shares. Barclays boosted their price objective on shares of Lam Research from $250.00 to $255.00 and gave the stock an “equal weight” rating in a research note on Tuesday, March 10th. Sanford C. Bernstein lifted their price target on Lam Research from $275.00 to $285.00 and gave the company an “outperform” rating in a report on Monday, February 9th. Susquehanna set a $325.00 price target on Lam Research and gave the stock a “positive” rating in a research report on Thursday, January 29th. Oppenheimer restated an “outperform” rating and set a $265.00 price objective on shares of Lam Research in a research note on Thursday, January 29th. Finally, UBS Group set a $300.00 price objective on Lam Research in a research report on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $245.35.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.